0000899243-23-019970.txt : 20231018
0000899243-23-019970.hdr.sgml : 20231018
20231018163016
ACCESSION NUMBER: 0000899243-23-019970
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231018
DATE AS OF CHANGE: 20231018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gordon Christopher R
CENTRAL INDEX KEY: 0001432313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 231332522
MAIL ADDRESS:
STREET 1: C/O BAIN CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-16
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001432313
Gordon Christopher R
C/O BAIN CAPITAL INVESTORS, LLC
200 CLARENDON STREET
BOSTON
MA
02116
1
0
1
0
0
Common Stock
2023-10-16
4
P
0
5480052
22.81
A
65679781
I
See footnotes
Common Stock
3282
D
Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Christopher Gordon is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BC Perception. Voting and investment decisions with respect to securities held by BC Perception are made by the partners of BCI. As a result, Mr. Gordon may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Mr. Gordon disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering.
/s/ Christopher Gordon
2023-10-18